Edition:
United Kingdom

Hisamitsu Pharmaceutical Co Inc (4530.T)

4530.T on Tokyo Stock Exchange

5,040JPY
1:14am GMT
Change (% chg)

¥10 (+0.20%)
Prev Close
¥5,030
Open
¥5,120
Day's High
¥5,120
Day's Low
¥5,040
Volume
55,300
Avg. Vol
200,079
52-wk High
¥9,950
52-wk Low
¥4,730

Latest Key Developments (Source: Significant Developments)

Hisamitsu Pharmaceutical Signs Agreement With Kyowa Hakko Kirin For Parkinson's Disease Treatment Hisamitsu Is Developing
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Hisamitsu Pharmaceutical Co Inc <4530.T>::SIGNED SALES AGREEMENT WITH KYOWA HAKKO KIRIN FOR PARKINSON'S DISEASE TREATMENT HISAMITSU IS DEVELOPING.KYOWA HAKKO KIRIN WILL SELL ITS PARKINSON'S DISEASE TREATMENT IN JAPAN ONCE ITS APPLICATION IS APPROVED.EXPECTS ITS APPLICATION FOR MANUFACTURE AND SALES WILL BE APPROVED BY FEB 2020.  Full Article

Hisamitsu Pharmaceutical Expected To Post 15 PCt Drop In H1 Operating Profit To 11 BLn Yen - Nikkei
Friday, 5 Oct 2018 

Oct 5 (Reuters) - NIKKEI::HISAMITSU PHARMACEUTICAL EXPECTED TO POST 15 PERCENT DROP IN FIRST-HALF OPERATING PROFIT TO 11 BILLION YEN - NIKKEI.HISAMITSU PHARMACEUTICAL'S SALES FOR 6 MONTHS ENDED AUGUST APPEAR TO HAVE FALLEN 5 PERCENT TO ABOUT 70 BILLION YEN- NIKKEI.HISAMITSU PHARMACEUTICAL'S FY OPERATING PROFIT IS FORECAST TO SAG 9 PERCENT TO 24 BILLION YEN AS SALES INCH UP SLIGHTLY TO 148.5 BILLION YEN - NIKKEI.  Full Article

Hisamitsu Pharmaceutical Co's Operating Profit For March-May Qtr Likely Slid 12 Pct - Nikkei
Tuesday, 26 Jun 2018 

June 27 (Reuters) - Hisamitsu Pharmaceutical Co Inc <4530.T>::HISAMITSU PHARMACEUTICAL'S MARCH-MAY QUARTER SALES LIKELY SLIPPED 3% TO ABOUT 35 BILLION YEN - NIKKEI.HISAMITSU PHARMACEUTICAL CO OPERATING PROFIT FOR MARCH-MAY QUARTER LIKELY SLID 12 PERCENT ON YEAR TO ABOUT 4.5 BILLION YEN - NIKKEI .  Full Article

Noven files patent infringement lawsuit against Alvogen
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - ‍Noven Pharmaceuticals :‍Noven Pharmaceuticals says filed lawsuit in a U.S. court against Alvogen and Alvogen pine brook llc for patent infringement.Says Alvogen is seeking approval to market & sell generic version of Minivelle prior to expiration of 2 of Noven's orange book listed patents​.  Full Article

Hisamitsu Pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen - Nikkei
Friday, 22 Sep 2017 

Sept 22 (Reuters) - Nikkei::Hisamitsu pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen ($111 million) in the March-August period‍​ - Nikkei.Sales of Hisamitsu Pharmaceutical probably fell 1% to about 74 billion yen in the March-August period - Nikkei.Hisamitsu Pharmaceutical Co Inc expected to maintain its guidance for the fiscal year ending February 2018 - Nikkei.  Full Article